MESI

MESI is a Slovenian startup that specializes in the development and production of innovative medical devices for diagnostics. The company's slogan, "We are on the MISSION to simplify diagnostics in primary care and help discover diseases earlier," reflects its mission to provide predictive medical assessment tools that aid in the early detection of diseases, enabling successful treatment for all patients.

Their flagship product, the MESI ABI MD, is an automated ankle-brachial pressure measuring device that efficiently detects occlusions of main arteries in the lower extremities. This innovative device has significantly reduced the time and skill required for such diagnostics compared to traditional methods, showcasing the company's commitment to advancing diagnostic capabilities.

In addition to the MESI ABI MD, MESI introduced the MESI mTABLET in 2017, catering to the modern healthcare practice. This certified medical tablet integrates wireless diagnostic tools, patient records, and medical apps in one system, providing a comprehensive digital solution for medical practitioners.

The company's ISO 13485 certification and CE certification for all developed medical devices, along with their MDR compliance and FDA clearance

The recent €18.00M Venture Round investment from SHS Capital in June 22, 2023 signifies growing investor confidence in MESI and its potential to drive innovation and impact in the healthcare and medical devices industries.